Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenue $ 4,657 $ 3,672 $ 9,881 $ 7,149
Cost of sales (3,353) (1,904) (6,539) (3,241)
Gross profit 1,304 1,768 3,342 3,908
Expenses        
General and administrative 8,013 10,301 16,274 18,765
Sales and marketing 728 241 1,461 828
Research and development 359 305 771 583
Restructuring expenses (135) 0 3,873 0
Depreciation and amortization 537 524 1,054 1,103
Total expenses 9,502 11,371 23,433 21,279
Loss from operations (8,198) (9,603) (20,091) (17,371)
Other Expense (Income), net        
Interest and amortization of debt issuance cost 652 920 2,770 1,898
(Gain) loss on remeasurement of warrant liability (1,323) (1,176) (1,813) 3,675
Gain on investment (6,851) 0 (6,851) 0
Loss on debt extinguishment, net 0 0 2,263 0
Foreign exchange loss 307 80 652 839
Other expense (income), net 63 (485) 10 (1,087)
Total other (income) expenses, net (7,152) (661) (2,969) 5,325
Loss before income taxes and equity investment loss (1,046) (8,942) (17,122) (22,696)
Equity investment share of loss 0 14 64 25
Net loss $ (1,046) $ (8,956) $ (17,186) $ (22,721)
Net loss per share - basic (USD per share) $ (0.03) $ (0.35) $ (0.51) $ (0.90)
Net loss per share - diluted (USD per share) $ (0.03) $ (0.35) $ (0.51) $ (0.90)
Weighted-average common shares outstanding - basic (in shares) 39,559,793 25,588,987 33,792,261 25,311,077
Weighted-average common shares outstanding - diluted (in shares) 39,559,793 25,588,987 33,792,261 25,311,077